Nutraceutical Compounds Targeting Inflammasomes in Human Diseases

Area of Science:

• Molecular Biology
• Immunology
• Nutrition Science

Background:

• The inflammasome is a multi-protein complex sensing danger signals and initiating inflammatory responses via caspase-1 activation.
• NLRP3 inflammasome is a critical mediator in numerous inflammatory diseases.
• Growing interest links lifestyle, nutrition, and disease pathogenesis.

Purpose of the Study:

• To review the role of nutraceuticals in modulating NLRP3 inflammasome activation.
• To explore the therapeutic potential of nutraceuticals in diseases associated with NLRP3 inflammasome dysregulation.

Main Methods:

• Literature review of studies investigating nutraceuticals and NLRP3 inflammasome.
• Analysis of molecular pathways targeted by nutraceuticals.
• Synthesis of evidence linking nutraceuticals to disease outcomes.

Main Results:

• A diverse range of nutraceuticals exhibit anti-inflammatory properties by targeting various molecular pathways.
• Nutraceuticals demonstrate significant positive effects in cardiovascular diseases, neurological disorders, cancer, and type 2 diabetes.
• Evidence supports nutraceuticals as a complementary approach to managing inflammatory conditions.

Conclusions:

• Nutraceuticals offer a promising avenue for managing diseases driven by NLRP3 inflammasome activation.
• Targeting the NLRP3 inflammasome with nutraceuticals presents a potential strategy for disease prevention and treatment.
• Further research is warranted to elucidate specific mechanisms and optimize therapeutic applications.